Midazolam-induced learning and memory impairment is modulated by cannabinoid CB1 receptor agonist and antagonist
Journal of Cellular & Molecular Anesthesia,
Vol. 1 No. 1 (2016),
21 December 2015
,
Page 3-11
https://doi.org/10.22037/jcma.v1i1.10628
Abstract
Background: Memory impairment is a well-known effect of many benzodiazepine compounds which is mediated through their action on gamma-aminobutyric acid type A (GABAA) receptors. On the other hand, cannabinoids can affect learning and memory process through presynaptic modulation of the release of both excitatory glutamate and inhibitory GABA transmitters in brain regions involved in learning and memory. The aim of the present study was to investigate the effect of cannabinoids on memory impairment and long-term potentiation (LTP) reduction properties of the short acting benzodiazepine midazolam.Materials and Methods: One week after insertion of guide cannula by stereotaxic surgery, cannabinoid compounds or midazolam were administered by intracerebroventricular (i.c.v.) injection into lateral ventricle of male rats. Spatial memory task was evaluated using Morris water maze (MWM) test. Electrophysiological evaluation was done by field potential recording of hippocampal neurons in unconscious rats.
Results: In MWM test, while i.c.v. administration of AM251 (200 and 500 ng) per se could not change learning and memory function in rats, pretreatment of rats with AM251 (500 ng; i.c.v.) attenuated midazolam-induced memory impairment. In field potential recording, while i.c.v. administration of AM251 (500 ng) and WIN55212-2 (10 μg) did not have any effect on population spike amplitude, pretreatment of rats with both AM251 and WIN55212-2 significantly diminished midazolam-induced PS amplitude reduction in hippocampal neurons.
Conclusion: Our
Our results suggest the involvement of cannabinoid CB1 receptors in both memory impairment and LTP reduction in hippocampal neurons which was produced by midazolam. This interaction is likely through their effect on both GABAergic and glutamatergic receptors in hippocampus.
- Midazolam
- AM251
- WIN55212-2
- learning and memory
- longterm potentiation
- Morris water maze
How to Cite
References
Rudolph U, Knoflach F. Beyond classical BDZs: novel
therapeutic potential of GABAA receptor subtypes. Nat Rev Drug
Discov. 2011;10(9):685-97.
Olkkola KT, Ahonen J. MDZ and other BDZs. Springer; 2008. p.
-60.
Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M,
Dodd RH, et al. Benzodiazepine impairs and beta-carboline
enhances performance in learning and memory tasks. Nature.
;321(6073):864-6.
Savic MM, Obradovic DI, Ugresic ND, Bokonjic DR. Memory
effects of BDZs: memory stages and types versus binding-site
subtypes. Neural Plast. 2005;12(4):289-98.
Gafford GM, Parsons RG, Helmstetter FJ. Effects of post-training
hippocampal injections of MDZ on fear conditioning. Learning &
memory. 2005;12(6):573-8.
Dickinson-Anson H, Mesches MH, Coleman K, McGaugh JL.
Bicuculline administered into the amygdala blocks benzodiazepineinduced
amnesia. Behavioral and neural biology. 1993;60(1):1-4.
Evers AS, Maze M. Anesthetic Pharmacology: Physiologic
Principles and Clinical Practice: a Companion to Miller's
Anesthesia: Churchill Livingstone; 2004.
Bustos S, Maldonado H, Molina V. MDZ disrupts fear memory
reconsolidation. Neuroscience. 2006;139(3):831-42.
Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de
Costa BR, et al. Cannabinoid receptor localization in brain. Proc
Natl Acad Sci U S A. 1990;87(5):1932-6.
Phillips RG, LeDoux JE. Differential contribution of amygdala
and hippocampus to cued and contextual fear conditioning. Behav
Neurosci. 1992;106(2):274-85.
Piomelli D. The molecular logic of endocannabinoid signalling.
Nature Reviews Neuroscience. 2003;4(11):873-84.
Di Marzo V, Melck D, Bisogno T, De Petrocellis L.
Endocannabinoids: endogenous cannabinoid receptor ligands with
neuromodulatory action. Trends Neurosci. 1998;21(12):521-8.
Pamplona FA, Takahashi RN. WIN 55212-2 impairs contextual
fear conditioning through the activation of CB1 cannabinoid
receptors. Neurosci Lett. 2006;397(1-2):88-92.
Campolongo P, Roozendaal B, Trezza V, Hauer D, Schelling G,McGaugh JL, et al. Endocannabinoids in the rat basolateral
amygdala enhance memory consolidation and enable glucocorticoid
modulation of memory. Proc Natl Acad Sci U S A.
;106(12):4888-93.
Wilson RI, Nicoll RA. Endogenous cannabinoids mediate
retrograde signalling at hippocampal synapses. Nature.
;410(6828):588-92.
Ohno-Shosaku T, Maejima T, Kano M. Endogenous
cannabinoids mediate retrograde signals from depolarized
postsynaptic neurons to presynaptic terminals. Neuron.
;29(3):729-38.
Kreitzer AC, Regehr WG. Cerebellar depolarization-induced
suppression of inhibition is mediated by endogenous cannabinoids. J
Neurosci. 2001;21(20):RC174.
Hampson RE, Zhuang SY, Weiner JL, Deadwyler SA.
Functional significance of cannabinoid-mediated, depolarizationinduced
suppression of inhibition (DSI) in the hippocampus. J
Neurophysiol. 2003;90(1):55-64.
Ohno-Shosaku T, Tsubokawa H, Mizushima I, Yoneda N,
Zimmer A, Kano M. Presynaptic cannabinoid sensitivity is a major
determinant of depolarization-induced retrograde suppression at
hippocampal synapses. J Neurosci. 2002;22(10):3864-72.
Alijanpour S, Rezayof A, Zarrindast MR. Dorsal hippocampal
cannabinoid CB1 receptors mediate the interactive effects of nicotine
and ethanol on passive avoidance learning in mice. Addict Biol.
Paxinos G, Watson C. The rat brain in stereotaxic coordinates:
Academic press; 2007.
Kim D, Yoo K, Hwang I, Jung J, Won M, Choi S, et al.
Elevated voltage gated Cl-channel expression enhances fast pairedpulse
inhibition in the dentate gyrus of seizure sensitive gerbil.
Neuroscience research. 2005;51(1):45-53.
Lashgari R, Motamedi F, Asl S, Shahidi S, Komaki A.
Behavioral and electrophysiological studies of chronic oral
administration of L-type calcium channel blocker verapamil on
learning and memory in rats. Behavioural brain research.
;171(2):324-8.
Abush H, Akirav I. Cannabinoids modulate hippocampal
memory and plasticity. Hippocampus. 2010;20(10):1126-38.
Jamali-Raeufy N, Nasehi M, Zarrindast MR. Influence of Nmethyl
D-aspartate receptor mechanism on WIN55,212-2-induced
amnesia in rat dorsal hippocampus. Behav Pharmacol.
;22(7):645-54.
Piri M, Zarrindast MR. Modulation of WIN55,212-2 statedependent
memory by alpha2-adrenergic receptors of the dorsal
hippocampus. Arch Iran Med. 2011;14(6):389-95.
Segev A, Akirav I. Differential effects of cannabinoid receptor
agonist on social discrimination and contextual fear in amygdala and
hippocampus. Learn Mem. 2011;18(4):254-9.
Chapouthier G, Venault P. GABA-A receptor complex and
memory processes. Bentham Science Publishers; 2002. p. 841-51.
Mori K, Togashi H, Kojima T, Matsumoto M, Ohashi S, Ueno
K, et al. Different effects of anxiolytic agents, diazepam and 5-
HT1A agonist tandospirone, on hippocampal long-term potentiation
in vivo. Elsevier; 2001. p. 367-72.
Evans MS, Viola-McCabe KE. MDZ inhibits long-term
potentiation through modulation of GABAA receptors. Elsevier;
p. 347-57.
Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona
M, Le Fur G, et al. Improvement of memory in rodents by the
selective CB1 cannabinoid receptor antagonist, SR 141716.
Springer; 1996. p. 165-72.
Miller LL, Branconnier RJ. Cannabis: Effects on memory and
the cholinergic limbic system. American Psychological Association;
p. 441.
Mazzola C, Micale V, Drago F. Amnesia induced by [beta]-
amyloid fragments is counteracted by cannabinoid CB1 receptor
blockade. Elsevier; 2003. p. 219-25.
Slanina KA, Schweitzer P. Inhibition of cyclooxygenase-2
elicits a CB1-mediated decrease of excitatory transmission in rat
CA1 hippocampus. Elsevier; 2005. p. 653-9.
Hoffman AF, Oz M, Yang R, Lichtman AH, Lupica CR.
Opposing actions of chronic tetrahydrocannabinol and cannabinoid
antagonists on hippocampal long-term potentiation. Cold Spring
Harbor Lab; 2007. p. 63-74.
Carlson G, Wang Y, Alger BE. Endocannabinoids facilitate the
induction of LTP in the hippocampus. Nature America; 2002. p.
-4.
de Oliveira Alvares L, Pasqualini Genro B, Vaz Breda R,
Pedroso MF, Costa Da Costa J, Quillfeldt JA. AM251, a selective
antagonist of the CB1 receptor, inhibits the induction of long-term
potentiation and induces retrograde amnesia in rats. Elsevier; 2006.
p. 60-7.
Sperk G, Schwarzer C, Tsunashima K, Fuchs K, Sieghart W.
GABA(A) receptor subunits in the rat hippocampus I:
immunocytochemical distribution of 13 subunits. Neuroscience.
;80(4):987-1000.
Garcia-Gutierrez MS, Manzanares J. The cannabinoid CB1
receptor is involved in the anxiolytic, sedative and amnesic actions
of BDZs. J Psychopharmacol. 2010;24(5):757-65.
Hajos N, Ledent C, Freund TF. Novel cannabinoid-sensitive
receptor mediates inhibition of glutamatergic synaptic transmission
in the hippocampus. Elsevier; 2001. p. 1-4.
- Abstract Viewed: 362 times
- PDF Downloaded: 290 times